KR102954666B1 - 병리학적 염증에 대한 새로운 의학적 치료 - Google Patents
병리학적 염증에 대한 새로운 의학적 치료Info
- Publication number
- KR102954666B1 KR102954666B1 KR1020217006280A KR20217006280A KR102954666B1 KR 102954666 B1 KR102954666 B1 KR 102954666B1 KR 1020217006280 A KR1020217006280 A KR 1020217006280A KR 20217006280 A KR20217006280 A KR 20217006280A KR 102954666 B1 KR102954666 B1 KR 102954666B1
- Authority
- KR
- South Korea
- Prior art keywords
- ethyl
- hydrogen
- asa
- compound
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/30—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18189194.6 | 2018-08-15 | ||
| EP18189194 | 2018-08-15 | ||
| PCT/EP2019/071903 WO2020035554A1 (en) | 2018-08-15 | 2019-08-15 | A new medical treatment for pathologic inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20210045414A KR20210045414A (ko) | 2021-04-26 |
| KR102954666B1 true KR102954666B1 (ko) | 2026-04-20 |
Family
ID=63294023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020217006280A Active KR102954666B1 (ko) | 2018-08-15 | 2019-08-15 | 병리학적 염증에 대한 새로운 의학적 치료 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US11896564B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3836912B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7512251B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102954666B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN112770736B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019322564A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112021001984A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3108361A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL280548A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2021001349A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020035554A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102954667B1 (ko) * | 2018-08-15 | 2026-04-17 | 파마실 아베 | 치환된 벤즈아미드 및 치료법에서 이의 용도 |
| US11717500B2 (en) * | 2020-02-03 | 2023-08-08 | Pharmacyl Ab | Treatment of spondyloarthritis |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL281394A (cg-RX-API-DMAC7.html) | 1961-07-25 | |||
| US6100299A (en) * | 1996-03-08 | 2000-08-08 | Oxigene, Inc. | N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use |
| US6028111A (en) | 1996-03-08 | 2000-02-22 | Oxigene, Inc. | Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
| US6518312B2 (en) | 2000-07-05 | 2003-02-11 | Active Biotech Ab | Immune enhancement |
| US7157444B2 (en) | 2002-12-21 | 2007-01-02 | Deanna Jean Nelson | Aminosalicylate derivatives for treatment of inflammatory bowel disease |
| WO2005025498A2 (en) | 2003-09-08 | 2005-03-24 | Corus Pharma | Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation |
| SE0400235D0 (sv) | 2004-02-06 | 2004-02-06 | Active Biotech Ab | New composition containing quinoline compounds |
| DE102004011720B4 (de) | 2004-03-10 | 2008-04-03 | Bayer Schering Pharma Aktiengesellschaft | Radiohalogenierte Benzamidderivate und deren Verwendung in der Tumordiagnostik und Tumortherapie |
| ATE554770T1 (de) * | 2006-04-13 | 2012-05-15 | Taiho Pharmaceutical Co Ltd | Therapeutisches mittel gegen entzündliche darmerkrankungen |
| KR101216756B1 (ko) * | 2007-12-18 | 2012-12-28 | 메이지 세이카 파루마 가부시키가이샤 | 염증성 장질환의 예방 또는 치료제 |
| WO2018037103A1 (en) * | 2016-08-26 | 2018-03-01 | Idogen Ab | Procainamide for treating immune disorders and for modulating ido expression |
-
2019
- 2019-08-15 BR BR112021001984-7A patent/BR112021001984A2/pt not_active IP Right Cessation
- 2019-08-15 CN CN201980051160.XA patent/CN112770736B/zh active Active
- 2019-08-15 KR KR1020217006280A patent/KR102954666B1/ko active Active
- 2019-08-15 JP JP2021506258A patent/JP7512251B2/ja active Active
- 2019-08-15 AU AU2019322564A patent/AU2019322564A1/en not_active Abandoned
- 2019-08-15 EP EP19750131.5A patent/EP3836912B1/en active Active
- 2019-08-15 MX MX2021001349A patent/MX2021001349A/es unknown
- 2019-08-15 US US17/264,924 patent/US11896564B2/en active Active
- 2019-08-15 WO PCT/EP2019/071903 patent/WO2020035554A1/en not_active Ceased
- 2019-08-15 CA CA3108361A patent/CA3108361A1/en active Pending
-
2021
- 2021-02-01 IL IL280548A patent/IL280548A/en unknown
Non-Patent Citations (2)
| Title |
|---|
| Christian Wahl 등, J.Clin.Invest., Vol.101, 1998, pp.1163-1174. 1부.* |
| Hanna Lindgren 등, Molecular Immunology, Vol.38, 2001, pp.267-277. 1부.* |
Also Published As
| Publication number | Publication date |
|---|---|
| US20220087959A1 (en) | 2022-03-24 |
| EP3836912A1 (en) | 2021-06-23 |
| JP7512251B2 (ja) | 2024-07-08 |
| CA3108361A1 (en) | 2020-02-20 |
| EP3836912C0 (en) | 2024-05-01 |
| CN112770736B (zh) | 2025-01-21 |
| US11896564B2 (en) | 2024-02-13 |
| WO2020035554A1 (en) | 2020-02-20 |
| JP2022501315A (ja) | 2022-01-06 |
| EP3836912B1 (en) | 2024-05-01 |
| CN112770736A (zh) | 2021-05-07 |
| MX2021001349A (es) | 2021-04-13 |
| AU2019322564A1 (en) | 2021-03-25 |
| IL280548A (en) | 2021-03-25 |
| BR112021001984A2 (pt) | 2021-05-11 |
| KR20210045414A (ko) | 2021-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018251118A1 (en) | Pharmaceutical composition containing MOR agonist and KOR agonist, and uses thereof | |
| JP7181565B2 (ja) | Yap-tead結合を阻害する化合物、およびそれを有効成分として含有する癌の予防または治療用医薬組成物 | |
| WO2016159577A2 (ko) | 1,2 나프토퀴논 유도체 및 이의 제조방법 | |
| WO2020035040A1 (zh) | 3-芳氧基-3-五元杂芳基-丙胺类化合物及其用途 | |
| CN110179791B (zh) | 细胞坏死抑制剂tak-632及其作为药物的用途 | |
| US11896564B2 (en) | Medical treatment for pathologic inflammation | |
| WO2013170757A1 (zh) | 4-氨基喹唑啉异羟肟酸类化合物及作为抗肿瘤药物应用 | |
| CN115304593B (zh) | 苯并异噻唑化合物及其药物组合物和应用 | |
| US20250064761A1 (en) | Substituted benzamides and their use in therapy | |
| US11717500B2 (en) | Treatment of spondyloarthritis | |
| ES2396764B1 (es) | FÁRMACOS INHIBIDORES DE p38 Y APLICACIONES. | |
| JPWO2014129513A1 (ja) | 潰瘍性大腸炎の予防または治療剤と新規フラーレン誘導体 | |
| WO2024235218A1 (zh) | Hdac1/2选择性抑制剂及其用途 | |
| US20250241918A1 (en) | Novel use of pyrazolopyrimidine compound | |
| WO2011081445A2 (ko) | 에틸아미노 벤조산 유도체의 치료 용도 | |
| KR102532517B1 (ko) | 신규한 설폰아미드 화합물 및 이를 유효 성분으로 함유하는 암의 예방 또는 치료용 약제학적 조성물 | |
| TWI571459B (zh) | A novel fluorinated diphenyl glycolate compound or a salt thereof | |
| CN102807514A (zh) | 取代的苯二胺类衍生物及其制备方法和用途 | |
| UA119070C2 (uk) | ЗАСТОСУВАННЯ 5-МЕТИЛ-3-АРИЛ[1,2,4]ТРИАЗОЛО[4,3-a]ПІРИМІДИН-7-ОЛІВ ЯК СПОЛУК, ЩО МАЮТЬ АНАЛГЕТИЧНУ АКТИВНІСТЬ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| A201 | Request for examination | ||
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| T11-X000 | Administrative time limit extension requested |
St.27 status event code: U-3-3-T10-T11-oth-X000 |
|
| E13-X000 | Pre-grant limitation requested |
St.27 status event code: A-2-3-E10-E13-lim-X000 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| D22 | Grant of ip right intended |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D22-EXM-PE0701 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| F11 | Ip right granted following substantive examination |
Free format text: ST27 STATUS EVENT CODE: A-2-4-F10-F11-EXM-PR0701 (AS PROVIDED BY THE NATIONAL OFFICE) |
|
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| U12 | Designation fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U12-OTH-PR1002 (AS PROVIDED BY THE NATIONAL OFFICE) Year of fee payment: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| Q13 | Ip right document published |
Free format text: ST27 STATUS EVENT CODE: A-4-4-Q10-Q13-NAP-PG1601 (AS PROVIDED BY THE NATIONAL OFFICE) |